CXCL10 and breast cancer: In breast cancer, CAFs secrete a variety of cytokines, including CXCL10, IL6, and IL8, which promote glycogenolysis and inhibit glycogen synthesis in breast cancer cells, ultimately leading to an increase in glycolysis (31).